Predictors of sustained virologic response in hepatitis C genotype 4: beyond the usual suspects

Ann Saudi Med. 2009 Jan-Feb;29(1):1-3. doi: 10.4103/0256-4947.51810.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antiviral Agents / administration & dosage
  • Antiviral Agents / therapeutic use*
  • Drug Therapy, Combination
  • Genotype
  • Hepacivirus / drug effects*
  • Hepacivirus / genetics
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / genetics
  • Hepatitis C, Chronic / virology
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / therapeutic use
  • Polyethylene Glycols / administration & dosage
  • Polyethylene Glycols / therapeutic use
  • Recombinant Proteins
  • Ribavirin / administration & dosage
  • Ribavirin / therapeutic use

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2a